Results 131 to 140 of about 1,543,151 (246)
Liver‐directed therapies for colorectal liver metastases
Abstract Colorectal cancer is the third most common cancer diagnosed in the United States, with an anticipated 53,000 deaths from this disease in 2025. Greater than one in five patients will present with synchronous colorectal liver metastases (CRLMs), and 25%–30% will develop CRLMs during the course of the disease.
Andrew D. Folkerts +2 more
openaire +2 more sources
A lactate‐H3K18la epigenetic axis upregulates RPL11 to drive gemcitabine resistance in pancreatic cancer. RPL11 orchestrates chemoresistance through a dual, compartmentalized role: enhancing cytoplasmic protein synthesis via EEF1A1 stabilization and promoting nuclear DNA damage repair by co‐activating PARP14, thus ensuring robust cell survival ...
Lijun Zhao +10 more
wiley +1 more source
Treatment outcomes in colorectal cancer patients with synchronous liver metastases
The purpose of the study was to analyze the 2-year survival rates in colorectal cancer (CRC) patients with synchronous liver metastases after combined modality treatment including perioperative chemotherapy.Material and Methods. A pilot prospective study
A. Yu. Dobrodeev +9 more
doaj +1 more source
Liver Transplantation for Unresectable Colorectal Liver Metastases
Colorectal cancer (CRC) is the third most common malignancy worldwide and a leading cause of cancer-related death. Nearly half of CRC patients develop metastatic disease, with the liver being the most frequent site of metastases. While curative-intent surgical resection remains the gold standard for colorectal liver metastases (CRLM), most patients are
Yash Kadakia +3 more
openaire +3 more sources
Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer
Background and aims: The surgical strategy for treatment of synchronous liver metastases from colorectal cancer remains controversial. This retrospective analysis was conducted to compare the postoperative outcome and survival of patients receiving ...
C. Benckert +7 more
core +1 more source
A subset of tumor‐associated macrophages (TAMs) characterized by SPP1 expression is discovered, which may remodel the tumor microenvironment by potentially promoting CD4+ T cell stress and maintaining epithelial cell stemness through SPP1‐CD44, thereby potentially contributing to the proliferation and migration of tumor cells, which has been verified ...
Xinhui Yuan +5 more
wiley +1 more source
Liver transplantation for colorectal cancer with liver metastases
Abstract Over the last decade, multiple clinical trials have demonstrated a survival benefit for liver transplantation in colorectal cancer with liver metastases. Additionally, advances in donor organ preservation have expanded organ availability affording the opportunity to expand indications for liver transplantation, such as ...
Benjamin E Ueberroth +3 more
openaire +2 more sources
Morbidity and survival in liver resection for colorectal metastases
The book chapter (Chapter 7) addresses and describes various aspects regarding the issue of liver resection for liver metastases from colorectal ...
Giovannini, Ivo +7 more
core +1 more source
Tools for controlled selenol delivery are crucial for exploring Se‐related biology and medicine, but compound platforms for triggerable release of CH3SeH remain lacking. Herein, we report the first general triggered platform (TD‐MSe) for efficient cyclization release of CH3SeH in live cells.
Wenfang Liang +7 more
wiley +1 more source
Surgical Management of Colorectal Cancer Liver Metastases
The article outlines 2 principal methods of surgical management for the patients with colorectal cancer liver metastases: hepatectomy and radio-frequency ablation (RFA).
Alexander Valentinovich Soloshenko +5 more
core

